$1.73
0.074.22%
Last update: Oct 28, 4:00 PM
InflaRx NV (IFRX) Stock Price, Quote, News & History
IFRXNASDAQ
Analysts initiate: Sell GEV ($470); Buy IFRX ($8), LYNX ($21); Overweight FRSH ($18); Outperform NPWR ($2.75).
You can purchase shares of InflaRx (NASDAQ:IFRX) through any online brokerage.
Other companies in InflaRx’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
InflaRx has a consensus price target of $8.70.
The stock price for InflaRx (NASDAQ: IFRX) is $1.73 last updated October 28, 2026 at 4:00 PM EDT.
There are no upcoming dividends for InflaRx.
InflaRx does not have any upcoming earnings scheduled.
There is no upcoming split for InflaRx.
InflaRx is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
InflaRx NV is a biopharmaceutical company applying proprietary technologies to discover, develop and commercialize potent and specific inhibitors of the complement activation factor known as C5a and its receptor C5aR. With its therapeutic product...
